Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study (Q33466550)

27 July 2017

title

Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study (English)

1 reference

27 July 2017

main subject

Clostridium difficile

0 references

2

Erik Dubberke

1 reference

27 July 2017

Robert Orenstein

1

1 reference

27 July 2017

Robert Hardi

3

1 reference

27 July 2017

Arnab Ray

4

1 reference

27 July 2017

Kathleen Mullane

5

1 reference

27 July 2017

Darrell S Pardi

6

1 reference

27 July 2017

Mayur S Ramesh

7

1 reference

27 July 2017

PUNCH CD Investigators

8

1 reference

27 July 2017

language of work or name

English

0 references

publication date

12 November 2015

1 reference

Clinical Infectious Diseases

27 July 2017

published in

1 reference

27 July 2017

volume

62

1 reference

27 July 2017

issue

5

1 reference

27 July 2017

page(s)

596-602

1 reference

Burden of Clostridium difficile infection in the United States

27 July 2017

cites work

1 reference

Diagnosis and treatment of Clostridium difficile in adults: a systematic review.

21 January 2018

1 reference

Fecal bacteriotherapy for recurrent Clostridium difficile infection

21 January 2018

1 reference

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection

21 January 2018

1 reference

Can we identify patients at high risk of recurrent Clostridium difficile infection?

21 January 2018

1 reference

Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review

21 January 2018

1 reference

Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review

21 January 2018

1 reference

Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection

21 January 2018

1 reference

Patient perceptions of fecal microbiota transplantation for ulcerative colitis

21 January 2018

1 reference

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

21 January 2018

1 reference

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

21 January 2018

1 reference

Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

21 January 2018

1 reference

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

21 January 2018

1 reference

The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema

21 January 2018

1 reference

Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection

21 January 2018

1 reference

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook

21 January 2018

1 reference

Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients

21 January 2018

1 reference

Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection

21 January 2018

1 reference

Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection

21 January 2018

1 reference

Weight gain after fecal microbiota transplantation

21 January 2018

1 reference

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.

21 January 2018

1 reference

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

21 January 2018

1 reference

Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada

21 January 2018

1 reference

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

Management of Clostridium difficile infection: thinking inside and outside the box

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1093/CID/CIV938

1 reference

27 July 2017

1 reference